Molina’s 2026 “trough” is a rate-and-acuity lag story—painful near term, but with $11+ embedded EPS power once Medicaid rates reset, Florida CMS matures, and the portfolio pivots to duals.
Overview
Molina’s 2025 results illustrate a managed care industry turning point: revenue grew strongly, but profitability collapsed as medical utilization surged faster than state reimbursement rates could adjust. Total revenue rose to ~$45.4B (+11.7%), yet adjusted EPS fell to $11.03 (from $22.65) as medical care costs jumped ~14.7% and MCR deteriorated to 91.7%. The year was a “tale of two halves,” ending in a severe Q4 loss (adjusted -$2.75/sh) driven by broad utilization pressure across Medicaid, Medicare and Marketplace, plus unexpected retroactive California rate and risk corridor actions (~$2/sh impact). Management reset expectations with 2026 “trough” guidance (≥$5.00 adjusted EPS), attributing the low point to identifiable headwinds: Medicaid MCR pressure, Florida CMS ramp costs, MAPD underperformance ahead of a planned 2027 exit, and higher interest/taxes. The longer-term thesis is mean reversion: as Medicaid rates catch up and strategic portfolio changes take effect, Molina believes it has $11+ of embedded earnings power and a pathway to recovery in 2027–2028.